We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Incident planning for potent synthetic opioids arriving into the illicit drug market.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
The requirements for packaging HHGW
Find out if your university qualification means you're eligible for a High Potential Individual visa.
Listing of countries with a known occurrence of high consequence infectious disease (HCID).
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Confiscated and surrendered drugs will be tested to identify toxic substances in circulation and help prevent drug-related overdoses.
Common user charge rates and how the charge applies to imports entering Great Britain through the Port of Dover and Eurotunnel.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Information on the status of mpox as a high consequence infectious disease (HCID).
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
A form of IP that extends the protection of patented active ingredients present in pharmaceutical or plant protection products.
Authorisation decisions on the time-limited use of hazardous substances of very high concern under UK REACH.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).